First, we surveyed the landscape of peptides accessible to T cells by performing MHC capture, peptide elution and liquid chromatography with tandem mass spectrometry17 (LC–MS/MS; immunopeptidomics) on eight neuroblastoma cell-derived xenografts (CDX) and patient-derived xenografts (PDX). The gene discussed is HLA-C; the disease is neuroblastoma.